Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | HKHHY | VIV |
|---|---|---|
| Price | $37.07 | $12.62 |
| Change today | ▲ 0.57% | ▲ 9.36% |
| Market cap | $20.18B | $20.16B |
| Return, 3 months | -5.9% | -3.7% |
| Return, year to date | +2.3% | +13.2% |
| Return, 1 year | +13.2% | +9.2% |
| P/E (TTM) | 15.5 | 15.3 |
| P/B | 2.1 | 1.5 |
| P/E percentile vs own 5y | – | 22nd |
| Dividend yield | 3.03% | 7.62% |
| Revenue growth (YoY, latest qtr) | – | +7.6% |
| Net profit growth (YoY) | – | +17.1% |
| Gross margin | – | 45.0% |
| Operating margin | – | 17.1% |
| Net margin | – | 10.7% |
| Return on equity | – | 9.9% |
| Analyst target vs. price | – | +18.9% |
| Analyst buy share | – | 0% |
| RSI (14) | 38 | 68 |
| 30-day volatility | 18.3% | 31.6% |
| Max drawdown, 1 year | -19.7% | -31.2% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | – | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
